Salubrinal protects against Clostridium difficile toxin B-induced CT26 cell death

Shuyi Chen, Chunli Sun, Huawei Gu, Haiying Wang, Shan Li, Yi Ma, and Jufang Wang

School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China

Acta Biochim Biophys Sin 2017, 49: 228–237; doi: 10.1093/abbs/gmw139

Clostridium difficile (C. difficile) is considered to be the major cause of the antibiotic-associated diarrhea and pseudomembranous colitis in animals and humans. The prevalence of C. difficile infections (CDI) has been increasing since 2000. Two exotoxins of C. difficile, Toxin A (TcdA) and Toxin B (TcdB), are the main virulence factors of CDI, which can induce glucosylation of Rho GTPases in host cytosol, leading to cell morphological changes, cell apoptosis, and cell death. The mechanism of TcdB-induced cell death has been investigated for decades, but it is still not completely understood. It has been reported that TcdB induces endoplasmic reticulum stress via PERK-eIF2α signaling pathway in CT26 cell line (BALB/C mouse colon tumor cells). In this study, we found that salubrinal, a selective inhibitor of eIF2α dephosphorylation, efficiently protects CT26 cell line against TcdB-induced cell death and tried to explore the mechanism underlying in this protective effect. Our results demonstrated that salubrinal protects CT26 cells from TcdB-mediated cytotoxic and cytopathic effect, inhibits apoptosis and death of the toxin-exposed cells via caspase-9-dependent pathway, eIF2α signaling pathway, and autophagy. These findings will be helpful for the development of CDI therapies.

Salubrinal against Clostridium difficile TcdB-induced cell death

Summary of protective mechanism

阅读全文: http://www.abbs.org.cn/arts.asp?id=4126

获取全文: abbs@sibs.ac.cn

相关论文:

1 Probiotics for prevention of Clostridium difficile infection

2 Dietary trehalose enhances virulence of epidemic Clostridium difficile

3 Ulcerative colitis

4 Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

5 A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection

6 Clostridium difficile infection

7 Clostridium difficile infection: epidemiology, diagnosis and understanding transmission

8 Breakthroughs in the treatment and prevention of Clostridium difficile infection